Group 1 - The company, Dawei Co., Ltd. (300535), announced on November 10 that it will no longer disclose the number of shareholders at non-periodic reporting times, as this information is not mandated by laws and regulations [1]

Core Viewpoint - The company has announced the establishment of a subsidiary in Italy to strengthen its position in the chemical industry and expand its international market presence [1] Group 1 - On May 13, 2025, the company's sixth board meeting unanimously approved the proposal to set up an overseas subsidiary [1] - The establishment of the subsidiary is part of the company's strategic plan to enhance its chemical business [1] - The company has completed the business registration procedures in Italy and obtained a business license from the local Chamber of Commerce (CCIAA) [1]

证券代码：300535 证券简称：达威股份 公告编号：2025-062 近日，公司在意大利完成了上述孙公司的工商注册登记手续，并取得了由当 地工商会 CCIAA 颁发的营业执照，具体登记信息如下： 1、公司名称：DOWELL ITALIA S.R.L. 四川达威科技股份有限公司 公司名称（译文）：达威（意大利）有限公司 关于意大利孙公司完成工商注册登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 2025 年 5 月 13 日，四川达威科技股份有限公司（以下简称"公司"）第六届 董事会第十九次会议全票通过了《关于设立境外孙公司的议案》，为了夯实化学 品主业的优势地位，拓展化学品国际市场的战略需要，计划在意大利投资设立孙 公司，具体内容详见同日刊登在巨潮资讯网（www.cninfo.com.cn）的《关于设 立境外孙公司的公告》。 二、进展情况 2、税号及企业注册号：14404150964 3、注册资本：15,000 欧元 4、登记日期：2025 年 10 月 29 日 5、企业类型：有限责任公司 6、注册地：MILANO (MI) ...

Group 1 - The core viewpoint of the news is that Dawi Co., Ltd. has shown significant stock performance with a year-to-date increase of 64.08% and a recent rise of 5.32% over the last five trading days [1] - As of November 7, Dawi's stock price reached 21.38 yuan per share, with a market capitalization of 2.241 billion yuan [1] - The company operates in the chemical new materials sector, with its main business revenue composition being leather functional additives (38.32%), coating materials (22.23%), colorants (18.14%), and cleaning leather materials (15.47%) [1] Group 2 - As of September 30, the number of shareholders for Dawi Co., Ltd. decreased by 12.39% to 8,242, while the average circulating shares per person increased by 13.11% to 9,190 shares [2] - For the period from January to September 2025, Dawi reported a revenue of 529 million yuan, a year-on-year decrease of 1.96%, and a net profit attributable to the parent company of 26.64 million yuan, down 11.73% year-on-year [2] - The company has distributed a total of 71.68 million yuan in dividends since its A-share listing, with 7.34 million yuan distributed over the past three years [3]

Core Points - The company, Sichuan Dawi Technology Co., Ltd., announced the successful achievement of the initial grant conditions for its 2025 Restricted Stock Incentive Plan [2] - The company held its 25th meeting of the 6th Board of Directors on November 4, 2025, to approve the adjustment of the list of incentive objects and the number of granted rights [2] - A total of 5.2348 million restricted stocks will be granted to 175 eligible incentive objects at a price of 10.09 yuan per share, with the grant date set for November 4, 2025 [2]

Core Viewpoint - The company announced the approval of adjustments to its 2025 restricted stock incentive plan, including the list of recipients and the number of shares to be granted [1] Group 1 - The sixth board of directors will hold its 25th meeting on November 4, 2025, to review the proposals related to the incentive plan [1] - The company will grant a total of 5.2348 million restricted shares to 175 eligible recipients, with a grant price set at 10.09 yuan per share [1]

Group 1 - The company, Dawei Co., Ltd. (300535.SZ), announced that it will hold the 25th meeting of the 6th Board of Directors on November 4, 2025 [1] - The meeting will review and approve the proposal to adjust the list of incentive objects and the number of granted rights under the 2025 Restricted Stock Incentive Plan [1] - The company plans to grant a total of 5.2348 million restricted stocks to 175 eligible incentive objects at a grant price of 10.09 yuan per share [1]

Group 1 - The core point of the article is that Dawei Co., Ltd. (SZ 300535) held its 25th meeting of the sixth board of directors on November 4, 2025, to discuss the proposal for the first grant of restricted stock under the 2025 restricted stock incentive plan [1] - For the first half of 2025, Dawei Co., Ltd.'s revenue composition was 94.1% from chemicals and 5.9% from other businesses [1] - As of the report date, Dawei Co., Ltd. has a market capitalization of 2.2 billion yuan [1] Group 2 - The article highlights a significant increase in overseas orders for a certain industry, with a surge of 246%, covering over 50 countries and regions [1] - Entrepreneurs are warning about the risk of malicious competition expanding overseas, as some are selling at a loss [1]

（6）中国证监会认定的其他情形。 四川达威科技股份有限公司 薪酬与考核委员会关于公司2025年限制性股票激励计划 首次授予激励对象名单的核查意见（授予日） 四川达威科技股份有限公司（下称"公司"）董事会薪酬与考核委员会根据《中华 人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》、《上 市公司股权激励管理办法》（以下简称"《管理办法》"）、《深圳证券交易所创业板 股票上市规则》等的规定，对公司2025年限制性股票激励计划（以下简称"本次激励 计划"）首次授予激励对象名单进行核查，发表核查意见如下： 1、公司本次激励计划首次授予的激励对象不存在下列情形： （1）最近12个月内被证券交易所认定为不适当人选； （2）最近12个月内被中国证监会及其派出机构认定为不适当人选； （3）最近12个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施； （4）具有《公司法》规定的不得担任董事、高级管理人员情形的； （5）法律法规规定不得参与上市公司股权激励的； 2、公司本次激励计划首次授予的激励对象未包括公司的独立董事、单独或合 计持股5%以上股东或实际控制人及其配偶、父母、子女及 ...

证券代码：300535 证券简称：达威股份 公告编号：2025-059 四川达威科技股份有限公司 关于调整 2025 年限制性股票激励计划首次授予 激励对象名单及授予权益数量的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川达威科技股份有限公司（以下简称"公司"）于2025年11月4日召开第六 届董事会第二十五会议，审议通过了《关于调整2025年限制性股票激励计划首 次授予激励对象名单及授予权益数量的议案》，根据《上市公司股权激励管理 办法》（以下简称"《管理办法》"）《四川达威科技股份有限公司2025年限制 性股票激励计划（草案）》（以下简称"本激励计划"）的规定及2025年度第二 次临时股东会的授权，董事会对公司本激励计划首次授予激励对象名单及授予 数量进行相应的调整。现对有关事项公告如下： 一、本激励计划已履行的相关审批程序 1、2025 年 9 月 16 日，公司召开第六届董事会第二十三次会议，审议通 过了《关于<2025 年限制性股票激励计划（草案）>及摘要的议案》《关于 <2025 年限制性股票激励计划实施考核管理办法>的议案》《关于提请 ...